AFRIN
Pronunciation: ox-i-me-TAZ-oe-leen

What it isAlpha-1 and alpha-2 agonist causing local vasoconstriction; nasal congestion and rosacea erythema.
Why this oneThe same rapid topical vasoconstriction also makes it useful for epistaxis; systemic effects are small at labeled doses, but accidental ingestion by children can be serious.
What limits itContinuous nasal use beyond three days can cause severe rebound congestion and escalating spray dependence.
Principal riskRebound congestion after three days
Legacy pregnancy categoryC
Defining liabilityLocal irritation, sensitization or administration-site injury; negligible systemic toxicity at usual use.
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Nasal congestion | Adults & children ≥6 yr (with supervision) | 2-3 sprays each nostril q10-12h PRN | 2 doses per 24 h |
Renal Undefined
Hepatic Undefined
Do not exceed 2 doses in any 24-hour period
Available strengths
Pregnancy Undefined
Lactation Undefined
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 0.05 g/100 mL | spray | per unit | not offered |
Generic entry2021
Open Oxymetazoline in the interactive console ↗